Info Session: Mucosal Immunity Innovation (MucInn) Program
Join us for an info session on VITAL's Mucosal Immunity Innovation (MucInn) program.
This session is ideal for innovators, entrepreneurs, and biotech companies working to advance vaccine protection at mucosal surfaces with an initial focus on influenza.
What to Expect:
MucInn Overview and Scope
Applicant Eligibility & Solution Focus Areas
Insights into Funding Structure
Evaluation Criteria
You’ll have the opportunity to engage directly with the VITAL team during a live Q&A.
(Note: mRNA-based approaches are out of scope for this opportunity.)
Who Should Attend:
Biotech entrepreneurs, startups, and companies working on vaccine technologies
Innovators in mucosal immunity and respiratory infectious disease
Academic and non-profit researchers advancing preclinical translational vaccine science
Applicants from anywhere globally interested in regulatory approval, commercialization, and marketing solutions
BARDA Accelerator Network (BAN)
Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.
The BARDA Accelerator Network, comprised of 5 hubs, will serve as a global network supporting early-stage companies from around the world developing next-generation medical countermeasures (MCMs). The Hubs are focused on Diagnostics/Medical Devices, Therapeutics/Vaccines, Digital Health Tools, Special Populations, and Enabling Technologies.
Vaccine Innovation and Therapeutics Accelerator Launchpad (VITAL)
VITAL is a BARDA Accelerator Network Hub supporting the development and acceleration of next-generation therapeutic and vaccine platforms and technologies to promote health security. It is led by Start2 Group in partnership with Advise Connect Inspire (ACI) and BioInnovation Labs (BioLabs). VITAL provides a global innovation network to enable impactful collaborations between the U.S. and other health security communities and their innovation ecosystems around the world.